05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
In a whirlwind of legislation, rulemaking, guidance, and answers to FAQs on the CARES Act, inevitab...
Read More >
In the Matter of Giora Neeman v Town of Warwick, __AD3d__, 2020 NY Slip Op 03112, the Second Departm...
Read More >
In a recent decision, the Appellate Court of Illinois rejected a school board’s decision to termina...
Read More >
Issues affecting the accuracy of both traditional credit reports and employment and tenant backgroun...
Read More >
The Situation:The U.S. Department of Justice ("DOJ") has sued to block a proposed acquisition of Ale...
Read More >
It is a common scenario: An employee claims a particular supervisor causes too much stress, exacerba...
Read More >